5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with (-)-catechin-3-O-gallate in 1 studies
Studies (5-(tetradecyloxy)-2-furancarboxylic acid) | Trials (5-(tetradecyloxy)-2-furancarboxylic acid) | Recent Studies (post-2010) (5-(tetradecyloxy)-2-furancarboxylic acid) | Studies ((-)-catechin-3-O-gallate) | Trials ((-)-catechin-3-O-gallate) | Recent Studies (post-2010) ((-)-catechin-3-O-gallate) |
---|---|---|---|---|---|
51 | 0 | 16 | 14 | 0 | 8 |
Protein | Taxonomy | 5-(tetradecyloxy)-2-furancarboxylic acid (IC50) | (-)-catechin-3-O-gallate (IC50) |
---|---|---|---|
Glucose-6-phosphate 1-dehydrogenase | Saccharomyces cerevisiae S288C | 0.24 | |
Pyruvate kinase PKM | Homo sapiens (human) | 0.85 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 0.124 | |
6-phosphogluconate dehydrogenase, decarboxylating | Homo sapiens (human) | 1.28 | |
Beta-secretase 1 | Homo sapiens (human) | 6 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.22 | |
Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.3 | |
3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 1 | |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | 0.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abramson, HN | 1 |
1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and (-)-catechin-3-O-gallate
Article | Year |
---|---|
The lipogenesis pathway as a cancer target.
Topics: Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Biosynthetic Pathways; Fatty Acid Synthases; Fatty Acids; Humans; Lipogenesis; Models, Chemical; Molecular Structure; Neoplasms | 2011 |